Financhill
Back

Jazz Pharmaceuticals PLC 10K Form

Sell
42

JAZZ
Jazz Pharmaceuticals PLC

Last Price:
109.29
Seasonality Move:
12.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive JAZZ News And Ratings

See the #1 stock for the next 7 days that we like better than JAZZ

JAZZ Financial Statistics

Sales & Book Value

Annual Sales: $3.83B
Cash Flow: $324.26M
Price / Cash Flow: 7.35
Annual Sales: $60.94
Price / Book: 1.8

Profitability

EPS (TTM): 5.82000
Net Income (TTM): $394.92M
Gross Margin: $3.4B
Return on Equity: 10.84%
Return on Assets: 3.49%

Jazz Pharmaceuticals PLC Earnings Forecast

Key Jazz Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 19 years for JAZZ is 88.64%.
  • The Selling, General & Administrative Expenses for JAZZ have been equal to 35.03% of Gross Profit Margin.
  • The Research & Development expenses have been 22.16% of Revenue.
  • The Interest Expense is 69.77% of Operating Income.
  • The Net Earning history of JAZZ is 10.82% of Total Revenues.
  • Per Share Earnings over the last 20 years have been positive in 12 years.

Jazz Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: JAZZ
CUSIP: G50871
Website: jazzpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.52
Current Ratio: 2.37
Quick Ratio: 1.72

Price-to-Earnings

Trailing P/E Ratio: 17.94
Forward P/E Ratio: 5.08

JAZZ Technical Analysis vs Fundamental Analysis

Sell
42
Jazz Pharmaceuticals PLC (JAZZ) is a Sell

Is Jazz Pharmaceuticals PLC a Buy or a Sell?